Drug profile · INN
conjugated estrogens/medroxyprogesterone acetate
PREMPRO/PREMPHASE
conjugated estrogens/medroxyprogesterone acetate (PREMPRO/PREMPHASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — conjugated estrogens/medroxyprogesterone acetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 5
- Programs
- 74
- Data quality
- 0.84
Quick answer
conjugated estrogens/medroxyprogesterone acetate (PREMPRO/PREMPHASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 8865230
Compositions and methods for treating parasitic infections
granted -
CA 2723411
PROCEDE
granted -
TW 200942531
Crystal forms of a nitrocatechol
granted -
WO 2009084970
3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE
granted -
US 7148193
Compounds that bind to growth hormone receptor
granted
Frequently asked questions
What is conjugated estrogens/medroxyprogesterone acetate?
conjugated estrogens/medroxyprogesterone acetate (PREMPRO/PREMPHASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for conjugated estrogens/medroxyprogesterone acetate?
PREMPRO/PREMPHASE is a marketed brand name for conjugated estrogens/medroxyprogesterone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of conjugated estrogens/medroxyprogesterone acetate?
conjugated estrogens/medroxyprogesterone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.